Literature DB >> 27702554

SLC52A2 [p.P141T] and SLC52A3 [p.N21S] causing Brown-Vialetto-Van Laere Syndrome in an Indian patient: First genetically proven case with mutations in two riboflavin transporters.

Tamilarasan Udhayabanu1, Veedamali S Subramanian2, Trevor Teafatiller3, Vykuntaraju K Gowda4, Varun S Raghavan4, Perumal Varalakshmi1, Hamid M Said2, Balasubramaniem Ashokkumar5.   

Abstract

BACKGROUND: Brown-Vialetto-Van Laere Syndrome (BVVLS), a rare neurological disorder characterized by bulbar palsies and sensorineural deafness, is mainly associated with defective riboflavin transporters encoded by the SLC52A2 and SLC52A3 genes.
METHODS: Here we present a 16-year-old BVVLS patient belonging to a five generation consanguineous family from Indian ethnicity with two homozygous missense mutations viz., c.421C>A [p.P141T] in SLC52A2 and c.62A>G [p.N21S] in SLC52A3.
RESULTS: Functional characterization based on 3H-riboflavin uptake assay and live-cell confocal imaging revealed that the effect of mutation c.421C>A [p.P141T] identified in SLC52A2 had a slight reduction in riboflavin uptake; on the other hand, the c.62A>G [p.N21S] identified in SLC52A3 showed a drastic reduction in riboflavin uptake, which appeared to be due to impaired trafficking and membrane targeting of the hRFVT-3 protein.
CONCLUSIONS: This is the first report presenting mutations in both riboflavin transporters hRFVT-2 and hRFVT-3 in the same BVVLS patient. Also, c.62A>G [p.N21S] in SLC52A3 appears to contribute more to the disease phenotype in this patient than c.421C>A [p.P141T] in SLC52A2.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BVVLS; Motor neuronopathy; hRFVT-2; hRFVT-3

Mesh:

Substances:

Year:  2016        PMID: 27702554      PMCID: PMC5521005          DOI: 10.1016/j.cca.2016.09.022

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  17 in total

1.  An efficient one-step site-directed and site-saturation mutagenesis protocol.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

2.  Exome sequencing in Brown-Vialetto-van Laere syndrome.

Authors:  Janel O Johnson; J Raphael Gibbs; Lionel Van Maldergem; Henry Houlden; Andrew B Singleton
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 3.  Ponto-bulbar palsy with deafness (Vialetto-Van Laere syndrome).

Authors:  V Puri; A Rohtagi; P S Parihar
Journal:  Indian Pediatr       Date:  1996-02       Impact factor: 1.411

4.  Pontobulbar palsy and neurosensory deafness (Brown-Vialetto-Van Laere syndrome) with possible autosomal dominant inheritance.

Authors:  S A Hawkins; N C Nevin; A E Harding
Journal:  J Med Genet       Date:  1990-03       Impact factor: 6.318

5.  Auditory neuropathy spectrum disorder with Brown-Vialetto-Van Laere syndrome: challenges in hearing rehabilitation.

Authors:  R Chandran; M Alexander; P Naina; A Balraj
Journal:  J Laryngol Otol       Date:  2015-05       Impact factor: 1.469

6.  Four novel C20orf54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.

Authors:  Mitra Ansari Dezfouli; Samira Yadegari; Shahriar Nafissi; Elahe Elahi
Journal:  J Hum Genet       Date:  2012-06-21       Impact factor: 3.172

7.  Conditional (intestinal-specific) knockout of the riboflavin transporter-3 (RFVT-3) impairs riboflavin absorption.

Authors:  Veedamali S Subramanian; Nils Lambrecht; Christian Lytle; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-10       Impact factor: 4.052

8.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.

Authors:  Peter Green; Matthew Wiseman; Yanick J Crow; Henry Houlden; Shelley Riphagen; Jean-Pierre Lin; F Lucy Raymond; Anne-Marie Childs; Eamonn Sheridan; Sian Edwards; Dragana J Josifova
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

9.  Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.

Authors:  Janel O Johnson; J Raphael Gibbs; Andre Megarbane; J Andoni Urtizberea; Dena G Hernandez; A Reghan Foley; Sampath Arepalli; Amelie Pandraud; Javier Simón-Sánchez; Peter Clayton; Mary M Reilly; Francesco Muntoni; Yevgeniya Abramzon; Henry Houlden; Andrew B Singleton
Journal:  Brain       Date:  2012-06-26       Impact factor: 13.501

Review 10.  The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives.

Authors:  Annet M Bosch; Kevin Stroek; Nico G Abeling; Hans R Waterham; Lodewijk Ijlst; Ronald J A Wanders
Journal:  Orphanet J Rare Dis       Date:  2012-10-29       Impact factor: 4.123

View more
  6 in total

Review 1.  Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases.

Authors:  Tamilarasan Udhayabanu; Andreea Manole; Mohan Rajeshwari; Perumal Varalakshmi; Henry Houlden; Balasubramaniem Ashokkumar
Journal:  J Clin Med       Date:  2017-05-05       Impact factor: 4.241

2.  Identification of contributing genes of Huntington's disease by machine learning.

Authors:  Jack Cheng; Hsin-Ping Liu; Wei-Yong Lin; Fuu-Jen Tsai
Journal:  BMC Med Genomics       Date:  2020-11-23       Impact factor: 3.063

3.  First report of paternal uniparental disomy of chromosome 8 with SLC52A2 mutation in Brown-vialetto-van laere syndrome type 2 and an analysis of genotype-phenotype correlations.

Authors:  Siyu Zhao; Fengyu Che; Le Yang; Yanyan Zheng; Dong Wang; Ying Yang; Yan Wang
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

4.  Clinical, pathological and functional characterization of riboflavin-responsive neuropathy.

Authors:  Andreea Manole; Zane Jaunmuktane; Iain Hargreaves; Marthe H R Ludtmann; Vincenzo Salpietro; Oscar D Bello; Simon Pope; Amelie Pandraud; Alejandro Horga; Renata S Scalco; Abi Li; Balasubramaniem Ashokkumar; Charles M Lourenço; Simon Heales; Rita Horvath; Patrick F Chinnery; Camilo Toro; Andrew B Singleton; Thomas S Jacques; Andrey Y Abramov; Francesco Muntoni; Michael G Hanna; Mary M Reilly; Tamas Revesz; Dimitri M Kullmann; James E C Jepson; Henry Houlden
Journal:  Brain       Date:  2017-11-01       Impact factor: 13.501

5.  Reconstitution in Proteoliposomes of the Recombinant Human Riboflavin Transporter 2 (SLC52A2) Overexpressed in E. coli.

Authors:  Lara Console; Maria Tolomeo; Matilde Colella; Maria Barile; Cesare Indiveri
Journal:  Int J Mol Sci       Date:  2019-09-08       Impact factor: 5.923

6.  Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice.

Authors:  Congyun Jin; Atsushi Yonezawa; Hiroki Yoshimatsu; Satoshi Imai; Madoka Koyanagi; Kaori Yamanishi; Shunsaku Nakagawa; Kotaro Itohara; Tomohiro Omura; Takayuki Nakagawa; Junya Nagai; Kazuo Matsubara
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.